21st.BIO A/S: Financial statements 2025
CVR: 41554908
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
21st.BIO A/S (CVR 41554908) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -15,518,420 and a net result of DKK -127,801,300 compared with DKK -41,660,123 the year before. Equity in the 2025 report amounted to DKK 202,530,839. The solvency ratio was 59.4%. The company had 58 employees in the financial year.
- Gross Profit
- DKK -15,518,420
- Profit/Loss
- DKK -127,801,300
- Equity
- DKK 202,530,839
- Total Assets
- DKK 341,028,721
- Employees
- 58
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -15.5 mio. | -127.8 mio. | 202.5 mio. | 58 |
| 2024 | - | -17.2 mio. | -41.7 mio. | 330.3 mio. | 19 |
| 2023 | - | -9.8 mio. | -42.3 mio. | 294.8 mio. | 32 |
| 2022 | - | -21.9 mio. | -36.6 mio. | 262.6 mio. | 11 |
Official annual report
How creditworthy is 21st.BIO A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
21st.BIO A/S has published its annual report for 2024. Gross profit came to DKK -17,202,758, and the net result was DKK -41,660,123.
As of February 6, 2025, Anders Bendsen Spohr has joined the board of directors of 21st.BIO A/S.
As of February 6, 2025, Søren Møller has left the board of directors of 21st.BIO A/S.
As of January 6, 2025, Jose Arnau Martinez is registered as director of 21st.BIO A/S.
As of January 6, 2025, Henrik Marcus Geertz-Hansen is registered as director of 21st.BIO A/S.
As of January 6, 2025, Per Falholt has stepped down as director of 21st.BIO A/S.
As of January 6, 2025, Thorvald Uhrskov Ullum has stepped down as director of 21st.BIO A/S.
About 21st.BIO A/S
21st.BIO A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2020. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Copenhagen Bio Partners A/S. The management consists of Henrik Marcus Geertz-Hansen, Jose Arnau Martinez and Mikael Bechsgaard. The board consists of Anders Bendsen Spohr (chair), Claus Crone Fuglsang, Thomas Dal Stenfeldt Batchelor and Thomas Grotkjær. The company is owned by Novo Holdings A/S, NOVOZYMES A/S and Momentum Techinvest ApS. The company has 44 employees (2026). In 2025, the company reported a gross profit of DKK -15,518,420 and a net result of DKK -127,801,300 compared with DKK -41,660,123 the year before. Equity in the 2025 report amounted to DKK 202,530,839.